AstraZeneca
An Executive Director, Strategy, Oncology R&D at AstraZeneca owns the global Oncology R&D strategy, setting priorities for senior leadership and driving patient impact through strategic decision-making. The role involves shaping therapeutic area strategies, advising executive teams, and ensuring strategic alignment across the organization.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
14% above the average for this role
Executive Director, Head of US Bioscience, Small Molecules, Oncology Targeted Discovery
American Association of Physicists in Medicine
Executive Director Global Project Leader, Oncology R&D
American Association of Physicists in Medicine
Director, Strategic Planning
Merck & Co., Inc.
Executive Director, R&D Communications, Corporate Affairs
lifelancer
Therapeutic Area Strategy Director, Oncology & Hematology
Diversity Employment
Global Medical Affairs Leader, TDR
American Association of Physicists in Medicine